RN624 In Adult Patients With Chronic Low Back Pain

Completed · Phase 2 · Has a placebo group

Conditions studied: Low Back Pain

In brief

The primary objective of this study is to evaluate the analgesic efficacy of RN624 compared with placebo and compared with naproxen in the treatment of adult patients with chronic low back pain.

Key facts

Study ID
NCT00584870
Run by
Pfizer
People needed
220
Starts
2007-07-05
Expected to finish
2008-09-02
Last updated by the study team
2021-07-12

Who can join

Age: 18 and older, up to 90. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.